Cognoa

News

Rare disease, repurposing and the role of AI

Changing Faces: pharma supplier, DTx, and non-profit hires f...

A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below.

News

Andy Molnar named head of Digital Therapeutics Alliance

Former Cognoa executive Andy Molnar has been appointed chief executive of the Digital Therapeutics Alliance, a global trade association for companies developing evidence-based DTx products.

News

FDA grants swift approval to Cognoa's digital device for aut...

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval.

News

Cognoa files paediatric autism diagnosis device with FDA

Cognoa has filed for FDA approval of a digital device that could be used to diagnose autism, which the company argues could redefine care standards.

News

Cognoa preps FDA filing for digital autism diagnostic

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the

Views & Analysis